These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 33302322)

  • 1. Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy.
    Dees S; Ganesan R; Singh S; Grewal IS
    Eur J Immunol; 2021 Feb; 51(2):280-291. PubMed ID: 33302322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting regulatory T cells in tumors.
    Liu C; Workman CJ; Vignali DA
    FEBS J; 2016 Jul; 283(14):2731-48. PubMed ID: 26787424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treg Fragility: A Prerequisite for Effective Antitumor Immunity?
    Overacre-Delgoffe AE; Vignali DAA
    Cancer Immunol Res; 2018 Aug; 6(8):882-887. PubMed ID: 30068755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Treg cells in cancer immunotherapy.
    Tanaka A; Sakaguchi S
    Eur J Immunol; 2019 Aug; 49(8):1140-1146. PubMed ID: 31257581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis.
    Kumar P; Saini S; Prabhakar BS
    Semin Cancer Biol; 2020 Aug; 64():29-35. PubMed ID: 30716481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies.
    Nishikawa H; Koyama S
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34330764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells in cancer immunotherapy.
    Tanaka A; Sakaguchi S
    Cell Res; 2017 Jan; 27(1):109-118. PubMed ID: 27995907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical development of a novel CCR8/CTLA-4 bispecific antibody for cancer treatment by disrupting CTLA-4 signaling on CD8 T cells and specifically depleting tumor-resident Tregs.
    Guo C; Dai X; Du Y; Xiong X; Gui X
    Cancer Immunol Immunother; 2024 Aug; 73(10):210. PubMed ID: 39123089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of Cancer by Targeting Regulatory T cells.
    Chen BJ; Zhao JW; Zhang DH; Zheng AH; Wu GQ
    Int Immunopharmacol; 2022 Mar; 104():108469. PubMed ID: 35008005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity.
    Kalim KW; Yang JQ; Wunderlich M; Modur V; Nguyen P; Li Y; Wen T; Davis AK; Verma R; Lu QR; Jegga AG; Zheng Y; Guo F
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36427906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of regulatory T cells in cancer immunity.
    Takeuchi Y; Nishikawa H
    Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells in cancer immunotherapy.
    Nishikawa H; Sakaguchi S
    Curr Opin Immunol; 2014 Apr; 27():1-7. PubMed ID: 24413387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines.
    Ruter J; Barnett BG; Kryczek I; Brumlik MJ; Daniel BJ; Coukos G; Zou W; Curiel TJ
    Front Biosci (Landmark Ed); 2009 Jan; 14(5):1761-70. PubMed ID: 19273160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
    Wang H; Franco F; Ho PC
    Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-CCR4 mAb and regulatory T cells].
    Kurose K; Ohue Y; Oka M
    Gan To Kagaku Ryoho; 2013 Sep; 40(9):1150-5. PubMed ID: 24047773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting regulatory T cells.
    Ménétrier-Caux C; Curiel T; Faget J; Manuel M; Caux C; Zou W
    Target Oncol; 2012 Mar; 7(1):15-28. PubMed ID: 22327882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
    Ohue Y; Nishikawa H
    Cancer Sci; 2019 Jul; 110(7):2080-2089. PubMed ID: 31102428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells.
    Alissafi T; Hatzioannou A; Legaki AI; Varveri A; Verginis P
    J Autoimmun; 2019 Nov; 104():102310. PubMed ID: 31421963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells.
    Sasidharan Nair V; Elkord E
    Immunol Cell Biol; 2018 Jan; 96(1):21-33. PubMed ID: 29359507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.
    Aristin Revilla S; Kranenburg O; Coffer PJ
    Front Immunol; 2022; 13():903564. PubMed ID: 35874729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.